Evidence method
Level · gp.fundamentals.capex_revenue_ratio
46.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Mar 31, 2026
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001703057-26-000028General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-403.16% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
96.34% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
94.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-691.75% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
561.18% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
144.47% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 56.93%
- Current
- 46.07%
- Delta
- -10.86%
- Previous
- -174.76%
- Current
- -403.16%
- Delta
- -228.40%
- Previous
- 160.56%
- Current
- 96.34%
- Delta
- -64.22%
- Previous
- 8.43%
- Current
- 94.53%
- Delta
- 86.09%
- Previous
- -288.98%
- Current
- -691.75%
- Delta
- -402.77%
- Previous
- 248.68%
- Current
- 561.18%
- Delta
- 312.50%
- Previous
- 74.26%
- Current
- 144.47%
- Delta
- 70.21%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Analogous To · ABCL state analogue 4 →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_DECREASED →Transitioned To · ABCL CASH_GENERATION_DECREASED →Transitioned To · ABCL GROWTH_DECREASED →Transitioned To · ABCL INVENTORY_PRESSURE_INCREASED →Transitioned To · ABCL PROFITABILITY_DECREASED →Transitioned To · ABCL R_AND_D_INTENSITY_INCREASED →Transitioned To · ABCL SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.